Tocagen On The Rocks With Phase III Brain Cancer Study Failure

 
• By Joseph Haas
  
male doctor in studio, thumbs down, showing failed, bad news - Image
Tocagen's TOCA 5 trial missed the primary, all secondary endpoints

More from Clinical Trials

More from R&D